Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck

Purpose: We conducted a Phase II, clinical trial to evaluate the efficacy and safety of a biweekly gemcitabine and paclitaxel (GEMTAX) regimen as second-line treatment in patients with recurrent or metastatic unresectable, squamous cell carcinoma of the head and neck (SCCHN). The primary endpoint wa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ammar Sukari, Marwan Al-Hajeili, Mohamed Salem, Lance Heilbrun, Daryn Smith, George Yoo, John R Jacobs, Ho-Sheng Lin, Omer Kucuk
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2015
Materias:
gemcitabine
head and neck cancer
paclitaxel
Medicine
R
Acceso en línea:https://doaj.org/article/642e5877e9e5444c8713e272457c8790
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares